LEADER 02069nam a2200373 a 4500
001 1895571
005 20171111234726.0
008 031223s1999 ne a ob 101 0 eng d
020 |a 0203304241  |q (electronic bk.) 
020 |a 9780203304242  |q (electronic bk.) 
020 |a 9789057022968 
020 |a 9057022966 
040 |a N$T  |b eng  |e pn 
050 4 |a RC347  |b .I5 1999eb 
245 0 0 |a Inflammatory cells and mediators in CNS diseases /  |c edited by Robert R. Ruffolo, Jr. [and others]. 
260 |a Amsterdam :  |b Harwood Academic Publishers,  |c ©1999. 
300 |a 1 online resource (xxii, 518 pages) :  |b illustrations (some color). 
490 1 |a New horizons in therapeutics,  |x 1027-6580 
504 |a Includes bibliographical references and index. 
505 0 |a Book Cover; Title; Contents; Preface to the Series; Preface to the Volume; Contributors; Perspectives in Neuroinjury and Disease; Unique Aspects of Inflammation in the Central Nervous System; Parenchymal Cell Death and Leukocyte; Endothelial Cell Interaction in Acute Experimental Inflammation; Apoptosis in Neurodegenerative Diseases: New Therapeutic Opportunities; Constitutive Nitric Oxide Synthase and Ischemic/Excitotoxic Brain Injury; Osteopontin in Oxidative Stress Responses; Inducible Nitric Oxide Synthase Gene Expression and Ischemic Brain Damage. 
650 0 |a Central nervous system  |x Diseases. 
650 0 |a Inflammation. 
650 1 2 |a Central Nervous System Diseases  |x physiopathology. 
650 2 2 |a Apoptosis. 
650 2 2 |a Central Nervous System Diseases  |x therapy. 
650 2 2 |a Cytokines. 
650 2 2 |a Inflammation  |x physiopathology. 
650 2 2 |a Inflammation Mediators. 
650 7 |a SOCIAL SCIENCE  |x Anthropology  |x Physical. 
650 7 |a Central nervous system  |x Diseases. 
700 1 |a Ruffolo, Robert R. 
711 2 |a SmithKline Beecham Pharmaceuticals United States Research Symposium  |c King of Prussia, Pa.) 
856 4 0 |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=95552 
952 |a CY-NiOUC  |b 5a0464ea6c5ad14ac1eec106  |c 998a  |d 945l  |e -  |t 1  |x m  |z Books